Sedefov R - Search Results

1

Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures.

Evans-Brown M, Sedefov R. Evans-Brown M, et al. Among authors: sedefov r. Handb Exp Pharmacol. 2018;252:3-49. doi: 10.1007/164_2018_160. Handb Exp Pharmacol. 2018. PMID: 30194542 Review.

2

Legal highs on the Internet.

Hillebrand J, Olszewski D, Sedefov R. Hillebrand J, et al. Among authors: sedefov r. Subst Use Misuse. 2010 Feb;45(3):330-40. doi: 10.3109/10826080903443628. Subst Use Misuse. 2010. PMID: 20141450

3

Khat use and monitoring drug use in Europe: the current situation and issues for the future.

Griffiths P, Lopez D, Sedefov R, Gallegos A, Hughes B, Noor A, Royuela L. Griffiths P, et al. Among authors: sedefov r. J Ethnopharmacol. 2010 Dec 1;132(3):578-83. doi: 10.1016/j.jep.2010.04.046. Epub 2010 May 7. J Ethnopharmacol. 2010. PMID: 20452413 Review.

4

Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age.

Griffiths P, Evans-Brown M, Sedefov R. Griffiths P, et al. Among authors: sedefov r. Addiction. 2013 Oct;108(10):1700-3. doi: 10.1111/add.12287. Epub 2013 Jul 19. Addiction. 2013. PMID: 23865891 No abstract available.

5

The (mis)use of psychoactive medicines: getting the balance right in complex systems.

Griffiths P, Evans-Brown M, Sedefov R. Griffiths P, et al. Among authors: sedefov r. Addiction. 2014 Feb;109(2):182-3. doi: 10.1111/add.12306. Addiction. 2014. PMID: 24422610 No abstract available.

6

The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.

Mounteney J, Griffiths P, Sedefov R, Noor A, Vicente J, Simon R. Mounteney J, et al. Among authors: sedefov r. Addiction. 2016 Jan;111(1):34-48. doi: 10.1111/add.13056. Epub 2015 Sep 30. Addiction. 2016. PMID: 26419329 Review.

7

Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN).

Dines AM, Wood DM, Yates C, Heyerdahl F, Hovda KE, Giraudon I, Sedefov R, Dargan PI; Euro-DEN Research Group. Dines AM, et al. Among authors: sedefov r. Clin Toxicol (Phila). 2015 Nov;53(9):893-900. doi: 10.3109/15563650.2015.1088157. Clin Toxicol (Phila). 2015. PMID: 26503789

8

New psychoactive substances: driving greater complexity into the drug problem.

Evans-Brown M, Sedefov R. Evans-Brown M, et al. Among authors: sedefov r. Addiction. 2017 Jan;112(1):36-38. doi: 10.1111/add.13528. Epub 2016 Aug 21. Addiction. 2017. PMID: 27546297 No abstract available.

9

Assessing the toxicological significance of new psychoactive substances in fatalities.

Elliott S, Sedefov R, Evans-Brown M. Elliott S, et al. Among authors: sedefov r. Drug Test Anal. 2018 Jan;10(1):120-126. doi: 10.1002/dta.2225. Epub 2017 Jul 26. Drug Test Anal. 2018. PMID: 28635164 Review.

10

Drug affordability-potential tool for comparing illicit drug markets.

Groshkova T, Cunningham A, Royuela L, Singleton N, Saggers T, Sedefov R. Groshkova T, et al. Among authors: sedefov r. Int J Drug Policy. 2018 Jun;56:187-196. doi: 10.1016/j.drugpo.2018.01.021. Epub 2018 Feb 17. Int J Drug Policy. 2018. PMID: 29459212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results